Subtelomeric chromosomal abnormalities are emerging as an important cause of human genetic disorders. The scope of this investigation was to screen a selected group of children with idiopathic mental retardation for subtelomeric anomalies using the multiprobe telomeric FISH method and also to develop and test a new assay, the MAPH telomeric assay, in the same group of patients. The new MAPH telomeric assay uses the recently published MAPH methodology that permits the measurement of locus copy number by hybridisation with a specifically designed set of probes located at the end of human chromosomes. Seventy patients with idiopathic mental retardation have been screened using the established multiprobe telomeric FISH assay and the new MAPH telomeric assay, for all telomeres. One patient with de novo 8p subtelomeric deletion was identified. The new MAPH telomeric assay confirmed the same results in both normal and abnormal samples. This is the first description of the use of MAPH methodology to detect chromosomal imbalances near the telomeres in idiopathic mentally retarded patients. The new MAPH telomeric assay offers a new, fast, accurate and cost effective diagnostic tool to detect chromosomal imbalances near telomeres in mentally retarded patients, as well as the characterisation of known chromosomal abnormalities, spontaneous recurrent miscarriages, infertility, hematological malignancies, preimplantation genetic diagnosis, and other fields of clinical and research interests.
Introduction
Mental retardation is a common and distressing disorder that affects 3% of the population and its origins are poorly understood. 1 Our poor understanding of its origins hampers the provision of effective treatment and preventive regimens, and remains a major challenge for medical practice. The cause of moderate and severe mental retardation is chromosomal or monogenenic in 30 ± 40% of cases, environmental factors explain a further 10 ± 30% and for about 40% the cause is still unknown. 2, 3 In the case of mild mental retardation, chromosomal anomalies and environmental causes explain about 30% of cases and for the remaining 70% the cause is unknown. 4, 5 Standard cytogenetic analysis in children with mental retardation is usually performed by G-banding at an ISCN 550 G-band level. This method is capable of detecting DNA rearrangements of 5 ± 10 Mb or larger which is a limiting factor for the detection of subtle rearrangements in patients. Hypervariable DNA polymorph-isms (HVPs), detected by probes for variable number of tandem repeats (VNTRs) can be used to find cryptic chromosomal anomalies by observation of abnormal inheritance of alleles from the parents. 6 By using this method, several investigations revealed submicroscopic chromosomal deletions and rearrangements in subjects who have an apparently normal karyotype and thus provide evidence that such anomalies are an important unrecognised cause of mental retardation. 7, 8 As an alternative to whole genome screening for submicroscopic anomalies, two methods for detecting telomeric rearrangements have been developed and applied to investigate such anomalies in patients with idiopathic mental retardation. The first method relies on detecting deviation from Mendelian inheritance of alleles at polymorphic loci close to telomeres. 6, 8 Two studies have reported frequencies of 6 and 7.4% subtelomeric rearrangements in individuals reported as normal after routine cytogenetic analysis. 8, 9 The second method exploits FISH using telomeric probes on metaphase chromosomes, to assess directly whether there is a loss or gain of telomere copy number.
10,11
The largest study to date, by Knight et al using the multiprobe telomere FISH approach in 284 children with unexplained moderate to severe mental retardation and 182 children with mild retardation, indicated that subtle chromosome rearrangements occurred in 7.4 and 0.5% of cases respectively.
12
Telomere screening is a very useful diagnostic test and the first step towards the goal of high resolution analysis of the entire genome for chromosome rearrangements. 13 This study presents a new methodology for detecting subtelomeric abnormalities, namely the MAPH telomeric assay, which exploits the recently published MAPH with a new specifically designed set of telomeric probes. MAPH (Multiplex Amplifiable Probe Hybridisation) methodology permits the accurate determination of locus copy number in the genome.
14 Briefly, in this method a set of specifically designed probes, all flanked by the same primer-binding sites, is hybridised with the test DNA. After washing, specifically bound probes are detected by amplification using the primers flanking the probe region. Since an excess of probe is used, the amount of probe amplified should reflect the copy number of the corresponding locus in the sample.
14 This is the first description of the use of MAPH telomeric assay, as a fast, accurate and cost effective methodology to detect chromosomal imbalances near telomeres in mentally retarded patients, as compared with multiprobe telomeric FISH. 
Materials and methods

Sample selection
Multiprobe telomeric FISH assay
Fixed chromosome suspensions for FISH analysis were prepared from peripheral blood using standard procedures. The probe labelling, preparation of slide devices and the multiprobe FISH protocol were performed as previously described by Knight et al. 10 A complete set of all of the telomere specific clones was kindly provided to us by Dr J Flint (Table 1) . FISH analyses were done using the Cytovision ChromoFluor TM analyser (Applied Image Co.) and all images were saved on optical disks.
MAPH telomeric assay
The new MAPH telomeric assay uses the recently published MAPH methodology and a specifically designed set of probes located at the end of 41 human chromosomes ( Table 1 ). The MAPH probes were prepared using insert DNAs from the same telomere specific clones that were used in multiprobe FISH (Table 1) , except the probes for XpYp, which were prepared by PCR from published sequence. 16 Insert fragments from PAC clones were initially separated from the vectors using 30 U of NotI and 30 U of MluI, then run on 1% low melting agarose and recovered using b-Agarase. They were then digested with AluI, dephosphorylated with 20 U of Calf Intestinal Alkaline Phosphatase and finally run on a 1.5% agarose gel, against a 20 bp ladder for size-selection. Agarose blocks containing fragments from 100 ± 800 bp were cut out and purified with Qiagen kit (Qiagen Inc). The telomeric fragments were subcloned into the EcoRV site of pZero-2 (Invitrogen) and transformed into E. coli TOP 10 by electroporation. Single colonies from the transformed plates were transferred to microtitre plates. Replica nylon filters were hybridised with 20 ng 32 P-labelled genomic DNA to identify clones containing multicopy sequences. 17 Selected single copy probes were amplified directly from the bacterial cultures using the common primers PZA, and PZB. 14 Products
were initially run on a 3% agarose gel for the initial sizing and those in the range of 140 ± 700 bp were selected, end-labelled with 33 P and run on a 6% denaturing polyacrylamide gel for Subtelomeric screening using FISH and MAPH assays C Sismani et al 528 more accurate sizing. A minimum of one probe per chromosome end was selected for each and two mixes were developed with differently sized probes, namely ST1 and ST2 with 27 and 28 probes respectively (Table 1) . MAPH methodology was carried out as originally described. 14 
Results
Multiprobe telomeric FISH All of the 70 tested samples had at least 90% good quality metaphases within the hybridised area and good hybridisations were obtained. A minimum of five metaphases with . Finally, DNA samples from 60 out of 70 patients with idiopathic mental retardation that were previously examined with multiprobe telomere FISH (group d), were finally investigated in a blind study aimed to further characterise the probes and confirm the results obtained by multiprobe telomere FISH. The subtelomeric 8p deletion was easily detected by MAPH telomeric assay as the signal intensity of probe 15C3 from the 8p clone, was reduced (n.r=0.65) (Figure 2 ). Normalised ratios obtained from this probe from all other 59 samples were constant and clustered around 1.0. The results from the blind study obtained from MAPH telomeric assay confirmed both the samples with 8p deletion and all the other samples as normal. In summary, by combining our results from the four different experiments, we have a MAPH set with reliable, specific, single copy and informative probes from 33 ends.
Discussion
We report the results of a multiprobe FISH telomeric screening in a well-defined group of 70 patients aged 4 ± 20 with idiopathic mental retardation, as well as the development and testing of the new MAPH telomeric assay in the same group of patients. 
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This investigation is important as it provides information for the efficiency of screening of a clinically well-defined group of patients. Furthermore, the results are important for advancing our understanding of the pathogenesis of mental retardation and for the clinical management of affected children. This screening identified one child with moderate mental retardation, with a de novo 8pter subtelomeric deletion using both multiprobe telomeric FISH and MAPH telomeric assays independently. In the present study, the observed prevalence of subtelomeric chromosomal abnormalities is 3.6% (one out of 28: 95% confidence intervals 0 ± 10.4%) among moderate to severe idiopathic mental retardation patients and 0% (0 out of 42: 95% confidence intervals 0 ± 7.1%) among mild idiopathic mental retardation patients. The study of 70 subjects is not sufficient to estimate the frequency precisely, but is within the confidence limits observed in other studies. 12, 13 Multiprobe telomeric FISH screening assay is currently the method of choice for the detection of subtelomeric abnormalities. 9 ± 11,13,18 However, it is a very time-consuming, expensive and difficult technique that makes it hard to be adopted in routine screening or performed as a service by genetic diagnostic laboratories. We report, for the first time, the development of a new fast and cost effective method, the MAPH telomeric assay. This is the first test of the new assay and further development, testing and experience is clearly needed to optimise the efficiency and accuracy of the method. The first set of specifically designed probes ST1/ ST2 for all telomeres proved partially insufficient with only 33 of the 41 ends being screened with confidence. In spite of the incomplete informativeness of the ST1/ST2 probe set used in this pilot study, the telomeric MAPH assay confirmed both the normal and the one abnormal result among the patients tested. Despite the relatively low informativeness of the ST1/ST2 probe set used in this pilot study, screening with MAPH telomeric assay would be a cost-effective way to making diagnoses in children with unexplained mental retardation. Work in progress is aiming to assemble a set of MAPH probes (ST3) which can screen all 41 unique subtelomeric regions in a single assay, and this set will be further tested on a large number of well-defined groups of idiopathic mentally retarded patients. In summary, we have screened a group of 70 children with unexplained mental retardation and determined one subtelomeric anomaly using the well established multiprobe telomeric FISH method and an innovative MAPH telomeric assay independently. The development and testing of the new MAPH telomeric assay offer a new fast and cost effective diagnostic tool for the investigation of mental retardation, the characterisation of known chromosomal abnormalities, spontaneous recurrent miscarriages, infertility, hematological malignancies, preimplantation genetic diagnosis, the investigation of human telomere structure and function, identification of dosage sensitive genes involved in human genetic diseases and other fields of clinical and research interests. 
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